article thumbnail

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Express Pharma

Shanghvi has been with Sun Pharma since 2006, holding various roles across marketing, research and development (R&D), project management, procurement, and communications. The company announced the designation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

article thumbnail

Pharmaceutical Negotiations Decoded: Lessons from the Trenches

Drug Patent Watch

The deal showcased the importance of strategic alignment, cultural fit, and clear communication throughout the negotiation process. The collapsed talks between Pfizer and AstraZeneca in 2014 highlight the need for flexibility, realistic valuations, and a deep understanding of regulatory hurdles in cross-border deals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

FDA Law Blog: Biosimilars

By Dara Katcher Levy — Yesterday, FDA published a new Draft Guidance, “ Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers ” (SIUU Guidance or Draft Guidance).

article thumbnail

Digital Health Education for Health Professionals: What are the Next Steps?

The Digital Apothecary

Digital Health and Healthcare Professional Education Publications Integrating mHealth and mobile technology education into the pharmacy curriculum (2014) Using a hackathon for interprofessional health education opportunities (2015) Leveraging mobile smart devices to improve interprofessional communications in inpatient practice setting: A literature (..)

Inpatient 130
article thumbnail

UK £62 billion behind in R&D global investment share, report reveals

European Pharmaceutical Review

The UK’s share of global research and development ( R&D ) investment has fallen by a fifth since 2014, according to recent data analysis by the Institute for Public Policy Research (IPPR). percent in 2014. percent GDP R&D investment. percent to 3.4 IPPR indicated that state investment drives private sector investment.

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

article thumbnail

Now and Next Summit – Digital Therapeutics Quiz

PharmaState Academy

Scientific Communication for Pharma Marketing - Quiz Questions: 20 Passing Marks: 80% The number of attempts remaining is 1 Please fill in the required information to participate in the Quiz Competition. a) 60% b) 80% c) 40% d) 30% 6 / 20 What is the impact of personalized scientific communication on HCPs?